General Information

Submission will be done online through the PAO Annual Meeting website. Early Bird registration is a pre-requisite prior submission of abstract paper online. Deadline for the submission of abstracts for the PAO Annual Meeting will be on September 28, 2018 (Friday), 12:00 MN (Philippine Standard Time). The electronic stamp of the website will be used as the basis for determining the time and date of submission.

The Scientific Program Committee will decide acceptance or non-acceptance. Notification of acceptance will be through email. The PAO reserves the right to decide the manner of presentation of free papers (Oral Presentation or Poster Presentation).

RESIDENTS’ RESEARCH PAPER CONTEST

FELLOWS’ RESEARCH PAPER CONTEST

FREE PAPER

The Scientific Program Committee of the PAO Annual Meeting for 2018 is currently accepting abstracts for submission in the following categories:

  • Scientific Paper
  • Scientific Poster
  • Video

In addition to the comprehensive program being crafted featuring local and foreign experts in their fields, your submitted abstracts will be considered for inclusion in the final scientific program. The Scientific Program Committee reserves the right to accept, reject, and change the categories of abstracts submitted for presentation as it deems appropriate.

Submission of Abstracts: September 28, 2018 (Friday) 12:00 MN (Philippine Standard Time).

Authors will be notified of selection of abstracts by e-mail whether they are accepted for poster, oral presentation or video presentation.

IMPORTANT REMINDERS FOR SUBMISSION:

1. Abstracts may only be submitted online. Authors need not be registered to submit abstracts but must be registered during the early bird registration period to be able to present their papers, whether it be as an oral presentation, poster presentation, or video. The deadline for submission will be strictly followed. Past this deadline, no abstracts will be accepted.

2. Presenters will be notified by the PAO of the status of their abstracts. Submission of an abstract constitutes a commitment by the author/s to present if selected for the Final Program.

3. All presenters are required to pre-register for the meeting (see Registration Guidelines) and pay all applicable fees PRIOR paper presentation and inclusion in the Final Program. This can be accomplished as soon as notification is received by the author/s. Last day for Early Bird Registration is on August 17, 2018 (Friday).

4. All authors/presenters are required to register their personal information details (even without paying yet) in order to submit their abstracts online. Authors/Presenters are advised to make sure that the same email address and password are used, both for submitting their abstracts and for completing/paying for their registration online.


SCIENTIFIC PROGRAM CATEGORIES:

• Cataract and Refractive Surgery
• Glaucoma
• Oculoplasty-Orbit
• Retina and Vitreous
• External Disease, Cornea and Eye Banking
• Neuro-ophthalmology
• Motility-Pediatric Ophthalmology
• Ocular Inflammation
• Public Health/Preventive Ophthalmology
• Evidence-Based Ophthalmology
• Ocular Pathology and Oncology
• Optics and Refraction – Contact Lens
• Low Vision

 

INSTRUCTIONS FOR ABSTRACT SUBMISSION:

  1. Abstracts must be in English.
  2. Abstracts will be reproduced exactly as submitted. Edit your abstract to avoid errors and misspellings. Your abstract may be rejected for publication if it is not comprehensible.
  3. Please check the appropriate boxes on the side and fill in all blanks at the bottom. Ensure that the abstract form is completely filled out before submission.
  4. Title : CAPITALIZE the entire title within the area provided. It should be informative, concise, meaningful, as brief as possible and no longer than 135 characters.
  5. Author/s : Give the full name of every author, including degrees, but omit titles or institutional appointments. Presenting author’s name should be mentioned first.
  6. Institution/s : Indicate the name and address of the institution/s where the research work was carried out.
  7. Text : Abstracts should contain adequate and pertinent information describing the contents of the scientific paper. The text must not exceed 250 words and should be arranged in the following format:
    • Objective
    • Methods
    • Results
    • Conclusions
  8. Abbreviations, acronyms and symbols should be defined the first time they are used. Place the abbreviation in parentheses after the full word.
  9. Use generic names of drugs.
  10. Proprietary and/or financial interests in any products (or competing products) described in the abstract must be disclosed.

ABSTRACT SAMPLES

Case Reports/Series:

TREATMENT OF OCULAR TOXOPLASMOSIS IN PREGNANCY

Leila I. Kump, MD, Ian Paredes, MD, C. Stephen Foster, MD
Massachusetts Eye and Ear Infirmary, Harvard Medical School,
Boston, Massachusetts, USA

Objective: To describe the course of ocular toxoplasmosis during pregnancy.

Methods: This is a retrospective, non-comparative case series of four pregnant women who were treated for ocular toxoplasmosis during pregnancy.

Results: All of the participants had violent and treatment-resistant toxoplasma retinochoroiditis during pregnancy, leaving three of them with decreased visual acuity in spite of aggressive therapy. Termination of pregnancy appeared to help in the recovery in two patients.

Conclusion: Pregnant state may provoke the recurrence of ocular toxoplasmosis.

Submissions other than Case Reports/Series

CORRELATION OF CENTRAL CORNEAL THICKNESS AND GOLDMANN APPLANATION TONOMETRY AMONG FILIPINOS

Ma. Margarita L. Lat-Luna, MD, Paul I Guerrero, MD, John Vincent Policarpio D. Flores, MD, MS Epi
University of the Philippines – Philippine General Hospital, Manila, Philippines

Objective: This study aims to determine the distribution of central corneal thickness (CCT) among Filipinos and to correlate CCT with intraocular pressure (IOP).

Methods: A prospective cross-sectional study was performed. Filipino patients consulting at the Ophthalmology General Clinic of the Philippine General Hospital were examined for CCT using an ultrasonic pachymeter and IOP using a Goldmann applanation tonometer.

Results: Two hundred twenty two eyes of 112 patients were included in the study. CCT ranged from 451.0 microns to 653.6 microns with a mean of 531.5 microns +/- 33.8 microns. There was a significant linear correlation between CCT and IOP (r=0.63). The IOP was noted to rise by 4.3 mmHg/100 microns CCT.

Conclusion: The findings of the study show that the CCT among Filipinos is normally distributed and is comparable to the distribution obtained by meta-analysis of worldwide data. The study also found a direct correlation between CCT and IOP.

Title / Author / Institution format (if 2 or more institutions are involved):

THE IMPLICATION OF RANDOMIZED, CONTROLLED CLINICAL TRIALS IN GLAUCOMA ON CLINICAL PRACTICE: WHAT DOES THE EVIDENCE TELL US?

Patricia M. Khu MD, MS (1,3), Joseph Anthony J. Tumbocon, MD (2,3), Jose Ma. G. Martinez, MD (4), Jesus Altuna, MD (4)

(1) Department of Ophthalmology and Visual Sciences, University of the Philippines – Philippine General Hospital, Manila, Philippines

(2) Institute of Ophthalmology, St. Luke’s Medical Center, Quezon City, Philippines

(3) Department of Ophthalmology, Cardinal Santos Medical Center San Juan, Metro Manila, Philippines

(4) Department of Ophthalmology, East Avenue Medical Center, Quezon City, Philippines